Pregnant women with red cell antibodies (SNCG) (1034)

Please report any inaccuracies or issues with this guideline using our online form

Women with red cell antibodies during pregnancy are at risk of developing Haemolytic disease of the fetus and newborn (HDFN). The aim of this guideline is to outline the management of pregnant women in whom red cell antibodies are identified. The guidance draws on existing UK professional guidelines produced by the British Society of Haematology (BSH) and the Royal College of Obstetricians and Gynaecologists (RCOG) and other relevant literature as cited in the references, towards the end of this document.

Optimal care of pregnant women with red cell antibodies may involve professionals from several disciplines (General Practice, Obstetrics, Midwifery, Neonatology and the Transfusion Laboratory). This guidance is relevant to all members of the multidisciplinary team that may be involved in the care of these women in Scotland. Timely and accurate communication between all those involved is essential to ensure the best outcome for mother and child. To facilitate communication and documentation, a ‘Record of Care’ document has been developed in parallel with this guidance.

The production of this guidance has been facilitated by the Scottish National Blood Transfusion Service (SNBTS) Transfusion Team with input from specialists in maternity care and transfusion medicine.